Healthcare Professionals
Latest research
Publications
Safety, Efficacy and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients with EGFR- mutated Advanced NSCLC: a Multicenter, Open-label, Phase I Trial

09 Sep 2020

Safety, Efficacy and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients with EGFR- mutated Advanced NSCLC: a Multicenter, Open-label, Phase I Trial.

Written by

Chih-Hsin Yang J, Camidge DR, Yang CT, Zhou J, Guo R, Chiu CH, Chang GC, Shiah HS, Chen Y, Wang CC, Berz D, Su WC, Yang N, Wang Z, Fang J, Chen J, Nikolinakos P, Lu Y, Pan H, Maniam A, Bazhenova L, Shirai K, Willis M, Masood N, Chowhan N, Hsia TC, Jian H, Lu S